Champlain Investment Partners, LLC

Position in PRCT — PROCEPT BioRobotics Corp

CIK 1315478 BURLINGTON, VT

Position in PRCT

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$28,419,413

-$16,915,516 QoQ

Shares Held

1,136,322

-21.1% QoQ

Ownership

2.00%

of shares outstanding

% of Portfolio

0.36%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 93.7288902265379.ToString("F0")% Shared 0.ToString("F0")% None 6.2711097734621.ToString("F0")%

Healthcare · as of Mar 31, 2026

Champlain Investment Partners, LLC holds $466,177,442 across 10 Medical Devices names. PRCT ranks #6 (6.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	PEN	Penumbra Inc	491,382	$161,355,107
2	EW	Edwards Lifesciences Corp	1,033,497	$82,762,439
3	STE	STERIS plc	284,275	$62,861,730
4	GKOS	GLAUKOS Corp	319,027	$34,346,446
5	GMED	Globus Medical Inc	350,053	$30,160,566
6	PRCT	PROCEPT BioRobotics Corp This page	1,136,322	$28,419,413
7	MASI	Masimo Corp	141,284	$25,130,185
8	BRKR	Bruker Corp	605,115	$21,856,753

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$28,419,413	1,136,322	-21.1%	Shares	Sole	2026-05-13
2025-12-31	$45,334,929	1,441,034	+0.2%	Shares	Sole	2026-02-13
2025-09-30	$51,318,543	1,437,897	+34.3%	Shares	Sole	2025-11-12
2025-06-30	$61,669,209	1,070,646	+58.3%	Shares	Sole	2025-08-12
2025-03-31	$39,395,178	676,196	+48.0%	Shares	Sole	2025-05-14
2024-12-31	$36,792,003	456,930	-29.7%	Shares	Sole	2025-02-13
2024-09-30	$52,101,475	650,293	-52.4%	Shares	Sole	2024-11-12
2024-06-30	$83,404,894	1,365,279	-13.2%	Shares	Sole	2024-08-14
2024-03-31	$77,703,510	1,572,309	-1.0%	Shares	Sole	2024-05-13
2023-12-31	$66,554,714	1,588,039	+1.3%	Shares	Sole	2024-02-13
2023-09-30	$51,459,007	1,568,394	—	Shares	Sole	2023-11-13
No filing history on record for this holder in this stock.